Welcome to #1 DIGITAL HEALTH NEWS Portal

FDA Releases Artificial Intelligence / Machine Learning Action Plan

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.

Read more ...

First NHS Trust and Sectra Achieve Rapid Go-Live in Greater Manchester Patient Diagnostic Imaging Initiative

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute has become the first of eight trusts across Greater Manchester to deploy state-of-the-art medical imaging technology.

Read more ...

The Institute of Healthcare Management Calls for Openness and Honesty about NHS Capacity as Sickness Absence Soars

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service.

The UK's leading, independent, membership organisation for health and social care managers also said local leaders and communications teams should be allowed to level with the public about their situation, as almost two thirds of poll respondents reported 'worse' or 'much worse' absence levels than they would expect at this time of year.

Read more ...

CliniSys Launches Laboratory Information Management System for Genomic Laboratories

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being successfully deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months.

Read more ...

Using Artificial Intelligence to Find New Uses for Existing Medications

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.

The intent of this work is to speed up drug repurposing, which is not a new concept - think Botox injections, first approved to treat crossed eyes and now a migraine treatment and top cosmetic strategy to reduce the appearance of wrinkles.

Read more ...

One in Four Doctors Attacked, Harassed on Social Media

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians also report being sexually harassed and personally attacked on these platforms on the basis of their religion, race or medical recommendations.

Read more ...

Associate Director Strategic Digital Partnerships

For more than 125 years, MSD company has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of the mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Read more ...

New Virtual Screening Strategy Identifies Existing Drug that Inhibits COVID-19 Virus

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.

Read more ...

Significant Disparities in Telemedicine Use, Especially Among Older and Non-White Patients

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends, it has impacted the way many receive medical care. Historically, the United States has been relatively slow to broadly adopt telemedicine, largely emphasizing in-person visits.

Read more ...

Model Used to Evaluate Lockdowns was Flawed

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model had fundamental shortcomings and cannot be used to draw the published conclusions, claim Swedish researchers from Lund University, and other institutions, in the journal Nature.

Read more ...